Bone Marrow Transplant Program for Acute Myeloid Leukemia at OHSU
BMT Core - Oregon Health and Science University (OHSU) Consortium
This program helps patients with acute myeloid leukemia (AML) receive bone marrow transplants to improve their chances of a successful recovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11166395 on NIH RePORTER |
What this research studies
Bone marrow transplants are a key treatment for acute myeloid leukemia (AML), and this program aims to enhance patient outcomes. Recent progress means more older adults and those with other health issues can now have these life-saving transplants. New targeted therapies are also being developed to prepare patients for transplant and improve results. A big challenge is when AML comes back after transplant, so this program also looks for ways to prevent that by detecting minimal residual disease.
Who could benefit from this research
Good fit: Patients with acute myeloid leukemia (AML), including those 21 years and older, especially older adults aged 65 and above, may be ideal candidates.
Not a fit: Patients who do not have acute myeloid leukemia or are not candidates for bone marrow transplantation would not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could lead to better long-term survival and fewer relapses for patients with acute myeloid leukemia undergoing bone marrow transplants.
How similar studies have performed: Advances in transplantation and targeted therapies have already shown promise in improving outcomes for patients with acute myeloid leukemia.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Maziarz, Richard Thomas — Oregon Health & Science University
- Study coordinator: Maziarz, Richard Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.